Shrinivas Bishu - Publications

Affiliations: 
2011-2015 University of Pittsburgh, Pittsburgh, PA, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Uddin J, Tomar S, Sharma A, Waggoner L, Ganesan V, Marella S, Yang Y, Noah T, Vanoni S, Patterson A, Zeng C, Foster PS, Newberry R, Bishu S, Kao JY, et al. PIR-B Regulates CD4 IL-17a T Cell Survival and Restricts T-cell Dependent Intestinal Inflammatory Responses. Cellular and Molecular Gastroenterology and Hepatology. PMID 34242819 DOI: 10.1016/j.jcmgh.2021.06.013  0.356
2020 Owyang SY, Zhang M, El-Zaatari M, Eaton KA, Bishu S, Hou G, Grasberger H, Kao JY. Dendritic cell-derived TGF-β mediates the induction of mucosal regulatory T-cell response to Helicobacter infection essential for maintenance of immune tolerance in mice. Helicobacter. e12763. PMID 33025641 DOI: 10.1111/hel.12763  0.454
2020 El-Zaatari M, Bishu S, Zhang M, Grasberger H, Hou G, Haley HR, Humphries BA, Syu LJ, Dlugosz A, Luker KE, Luker G, Eaton KA, Kamada N, Cascalho M, Kao JY. Aim2-Mediated/IFN-β-Independent Regulation of Gastric Metaplastic Lesions via CD8+ T Cells. Jci Insight. PMID 32053518 DOI: 10.1172/Jci.Insight.94035  0.319
2019 Bishu S, Hou G, El Zaatari M, Bishu SR, Popke D, Zhang M, Grasberger H, Zou W, Stidham RW, Higgins PDR, Spence JR, Kamada N, Kao JY. induces tissue-resident memory CD4 T-cells. Infection and Immunity. PMID 31061145 DOI: 10.1128/Iai.00295-19  0.421
2019 Bishu S, El Zaatari M, Hayashi A, Hou G, Bowers N, Kinnucan J, Manoogian B, Muza-Moons MM, Zhang M, Grasberger H, Bourque C, Zou W, Higgins PDR, Spence JR, Stidham RW, et al. CD4+ tissue-resident memory T-cells expand and are a major source of mucosal tumor necrosis factor α in active Crohn's Disease. Journal of Crohn's & Colitis. PMID 30715262 DOI: 10.1093/Ecco-Jcc/Jjz010  0.326
2019 Bishu S, El-Zaatari M, Hayashi A, Hou G, Bowers N, Kinnucan JA, Manoogian B, Muza-Moons M, Zhang M, Grasberger H, Zou W, Higgins PD, Spence J, Stidham RW, Kamada N, et al. Mo1877 – Tumor Necrosis Factor α and Il-17A Producing Cd4+ Tissue Resident Memory T-Cells are Expanded in Crohn’s and are Inhibited by the Anti-Inflammtory Microbial Metabolite Butyrate Gastroenterology. 156: S-872. DOI: 10.1016/S0016-5085(19)39144-9  0.371
2017 Bishu S, Koutroumpakis E, Mounzer R, Stello K, Pollock N, Evans A, Whitcomb DC, Papachristou GI. The -251 A/T Polymorphism in the IL8 Promoter is a Risk Factor for Acute Pancreatitis. Pancreas. PMID 29215544 DOI: 10.1097/MPA.0000000000000967  0.575
2015 Simpson-Abelson MR, Childs EE, Ferreira MC, Bishu S, Conti HR, Gaffen SL. C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins. Plos One. 10: e0136538. PMID 26317211 DOI: 10.1371/Journal.Pone.0136538  0.767
2014 Conti HR, Peterson AC, Brane L, Huppler AR, Hernández-Santos N, Whibley N, Garg AV, Simpson-Abelson MR, Gibson GA, Mamo AJ, Osborne LC, Bishu S, Ghilardi N, Siebenlist U, Watkins SC, et al. Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections. The Journal of Experimental Medicine. 211: 2075-84. PMID 25200028 DOI: 10.1084/Jem.20130877  0.562
2014 Bishu S, Su EW, Wilkerson ER, Reckley KA, Jones DM, McGeachy MJ, Gaffen SL, Levesque MC. Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses. Arthritis Research & Therapy. 16: R50. PMID 24513269 DOI: 10.1186/Ar4480  0.782
2014 Bishu S, Hernández-Santos N, Simpson-Abelson MR, Huppler AR, Conti HR, Ghilardi N, Mamo AJ, Gaffen SL. The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections. Infection and Immunity. 82: 1173-80. PMID 24379290 DOI: 10.1128/Iai.01335-13  0.668
2012 Huppler AR, Bishu S, Gaffen SL. Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. Arthritis Research & Therapy. 14: 217. PMID 22838497 DOI: 10.1186/Ar3893  0.834
Show low-probability matches.